Apotex Health Corp. (APTX) Q1 2027 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Apotex First Quarter Fiscal twenty twenty seven Earnings Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. Please note this event is being recorded. I would now like to turn the conference over to Kevin Mannix, Investor Relations. Please go ahead. Thank you, operator, and good morning, everyone. Our press release for the company's first quarter financial results and business update became available at six a. M. Eastern Time this morning and can be found on the Investor and News section of our website and SEDAR plus Before we start, we'd like to remind you that all amounts discussed on this call are denominated in Canadian dollars unless otherwise indicated. Please note that the statements made during this call may include forward looking statements and future oriented financial information regarding Apotex and its business. These statements are made as of the date hereof, and Apotex assumes no obligation to update or revise them except as required by applicable securities laws. These statements are based on certain assumptions and involve significant risks and uncertainties and are not a guarantee of future performance or results. Please refer to risk factors in the forward looking information sections of the company's public filings, which include, without limitation, Apotex's MD and A, its earnings press release issued today and its IPO prospectus for additional information. During this call, we will reference certain non IFRS financial measures. Please see our earnings press release and MD and A for a description of these measures and reconciliations to the most directly comparable IFRS measures. On today's call, we are joined by Jeff Watson, Apotex's Presiden...